This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Fatty liver disease, also known as hepatic steatosis, is a condition in which excess fat accumulates in the liver. It is a common disorder caused by a variety of factors including excessive alcohol intake, poor nutrition, metabolic disorders, and certain medications. In most cases, fatty liver disease is asymptomatic, but can sometimes cause symptoms such as abdominal pain, nausea, weight loss, and fatigue. The most common diagnostic test for fatty liver disease is a liver ultrasound. If left untreated, fatty liver disease can lead to more serious issues such as liver scarring (cirrhosis), liver cancer, and even death. Treatment depends on the cause of the disease, but may include lifestyle changes such as quitting smoking, limiting alcohol intake, exercising regularly, eating a healthy diet, and losing weight. Medications can also be used to help reduce the fat in the liver. Statins, fibrates, and niacin are all commonly prescribed drugs used to treat fatty liver disease. It is important to remember that fatty liver disease is a serious condition and should not be taken lightly.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States